Engaging patients and caregivers in an early health economic evaluation: Discerning treatment value based on lived experience
Health Affairs
State-level variation in low-value care for commercially insured and Medicare Advantage populations
Clinical Therapeutics
Incentivizing drug development in serious mental illness
Journal of Managed Care and Specialty Pharmacy
Characterizing health plan evidence review practices
Medical Care
Effect of the 2012 US Preventive Services Task Force recommendations on prostate-specific antigen screening in a Medicare advantage population
Applied Health Economics and Health Policy
Family spillover effects: Are economic evaluations misrepresenting the value of healthcare interventions to society?
Alzheimer's & Dementia
Alzheimer's disease medication use and adherence patterns by race and ethnicity
Journal of Managed Care & Specialty Pharmacy
When are breakthrough therapies cost-effective?
PharmacoEconomics Open
Should drug companies engage with ICER? An empirical analysis of how often manufacturers engage with ICER and whether engagement may influence ICER's cost-effectiveness estimates
